Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis

The efficacy and safety of incobotulinumtoxinA ≤400 U was demonstrated in subjects with post-stroke upper-limb spasticity in a randomized, double-blind Phase 3 study with an open-label extension (OLEX; EudraCT number 2005-003951-11, NCT00432666). We report a post-hoc analysis of the duration of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaňovský, Petr, Elovic, Elie P., Hanschmann, Angelika, Pulte, Irena, Althaus, Michael, Hiersemenzel, Reinhard, Marciniak, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862578/
https://www.ncbi.nlm.nih.gov/pubmed/33551974
http://dx.doi.org/10.3389/fneur.2020.615706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862578/
https://www.ncbi.nlm.nih.gov/pubmed/33551974
http://dx.doi.org/10.3389/fneur.2020.615706

Ejemplares similares